PHARMACOKINETICS, PHARMACODYNAMICS, AND TOLERABILITY OF VERINURAD (RDEA3170), A SELECTIVE URIC ACID REABSORPTION INHIBITOR, IN HEALTHY JAPANESE MALE SUBJECTS

被引：0
|
作者：
Gillen, M. [1 ]
Miner, J. N. [2 ]
Valdez, S. [2 ]
机构：
[1] AstraZeneca, Gaithersburg, MD USA
[2] Ardea Biosci Inc, San Diego, CA USA
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2017年 / 76卷
关键词：
D O I：
10.1136/annrheumdis-2017-eular.5200
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0887
引用
收藏
页码：1366 / 1366
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetics, Pharmacodynamics, Pharmacogenomics, Safety, and Tolerability of Avatrombopag in Healthy Japanese and White Subjects
    Nomoto, Maiko
    Pastino, Gina
    Rege, Bhaskar
    Aluri, Jagadeesh
    Ferry, Jim
    Han, David
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2018, 7 (02): : 188 - 195
  • [22] Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects
    Jane Knöchel
    Karin Nelander
    Maria Heijer
    Eva-Lotte Lindstedt
    Gun-Britt Forsberg
    Carl Whatling
    Hitoshi Shimada
    David S. Han
    Anders Gabrielsen
    Pavlo Garkaviy
    Hans Ericsson
    Clinical Drug Investigation, 2021, 41 : 895 - 905
  • [23] Pharmacokinetics, Pharmacodynamics, and Tolerability of AZD5718, an Oral 5-Lipoxygenase-Activating Protein (FLAP) Inhibitor, in Healthy Japanese Male Subjects
    Knochel, Jane
    Nelander, Karin
    Heijer, Maria
    Lindstedt, Eva-Lotte
    Forsberg, Gun-Britt
    Whatling, Carl
    Shimada, Hitoshi
    Han, David S.
    Gabrielsen, Anders
    Garkaviy, Pavlo
    Ericsson, Hans
    CLINICAL DRUG INVESTIGATION, 2021, 41 (10) : 895 - 905
  • [24] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
    Daniela Willen
    Wolfgang Uhl
    Peter Wolna
    Orestis Papasouliotis
    Özkan Yalkinoglu
    European Journal of Drug Metabolism and Pharmacokinetics, 2020, 45 : 27 - 40
  • [25] Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Atacicept in a Randomized Trial in Healthy Caucasian and Japanese Subjects
    Willen, Daniela
    Uhl, Wolfgang
    Wolna, Peter
    Papasouliotis, Orestis
    Yalkinoglu, Oezkan
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2020, 45 (01) : 27 - 40
  • [26] Clinical Pharmacokinetics, Pharmacodynamics, Safety and Tolerability of Darexaban, an Oral Direct Factor Xa Inhibitor, in Healthy Elderly Japanese Subjects
    Kadokura, Takeshi
    Oikawa, Keishi
    Miyata, Koji
    Murase, Toshinobu
    Nakamura, Mashio
    CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2013, 2 (04): : 328 - 335
  • [27] Clinical pharmacokinetics, pharmacodynamics, safety and tolerability of darexaban, an oral direct factor Xa inhibitor, in healthy Caucasian and Japanese subjects
    Kadokura, Takeshi
    Kashiwa, Makoto
    Groenendaal, Dorien
    Heeringa, Marten
    Mol, Roelof
    Verheggen, Frank
    Garcia-Hernandez, Alberto
    Onkels, Hartmut
    BIOPHARMACEUTICS & DRUG DISPOSITION, 2013, 34 (08) : 431 - 441
  • [28] Pharmacokinetics, pharmacodynamics, and tolerability of single increasing doses of the dipeptidyl peptidase-4 inhibitor alogliptin in healthy male subjects
    Christopher, Ronald
    Covington, Paul
    Davenport, Michael
    Fleck, Penny
    Mekki, Qais A.
    Wann, Elisabeth R.
    Karim, Aziz
    CLINICAL THERAPEUTICS, 2008, 30 (03) : 513 - 527
  • [29] Pharmacokinetics, pharmacodynamics and tolerability of opicapone, a novel COMT inhibitor, during multiple rising dose regimens in healthy male subjects
    Rocha, J. -F.
    Nunes, T.
    Vaz-da-Silva, M.
    Machado, R.
    Wright, L.
    Falcao, A.
    Almeida, L.
    Soares-da-Silva, P.
    EUROPEAN JOURNAL OF NEUROLOGY, 2012, 19 : 696 - 696
  • [30] PHARMACOKINETICS, PHARMACODYNAMICS AND SAFETY OF NC-2500, A NOVEL XANTHINE OXIDOREDUCTASE INHIBITOR, IN HEALTHY JAPANESE MALE SUBJECTS
    Hirano, M.
    Kobayashi, S.
    Miyayama, E.
    Ohtal, T.
    Yamamoto, M.
    Yamakawa, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2018, 77 : 1634 - 1635
12345